Virbac Balance Sheet Health

Financial Health criteria checks 6/6

Virbac has a total shareholder equity of €994.2M and total debt of €370.0M, which brings its debt-to-equity ratio to 37.2%. Its total assets and total liabilities are €1.8B and €802.0M respectively. Virbac's EBIT is €227.3M making its interest coverage ratio 87.6. It has cash and short-term investments of €158.6M.

Key information

37.2%

Debt to equity ratio

€369.96m

Debt

Interest coverage ratio87.6x
Cash€158.64m
Equity€994.24m
Total liabilities€801.99m
Total assets€1.80b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 0NM7's short term assets (€877.3M) exceed its short term liabilities (€530.6M).

Long Term Liabilities: 0NM7's short term assets (€877.3M) exceed its long term liabilities (€271.4M).


Debt to Equity History and Analysis

Debt Level: 0NM7's net debt to equity ratio (21.3%) is considered satisfactory.

Reducing Debt: 0NM7's debt to equity ratio has reduced from 94.1% to 37.2% over the past 5 years.

Debt Coverage: 0NM7's debt is well covered by operating cash flow (37.5%).

Interest Coverage: 0NM7's interest payments on its debt are well covered by EBIT (87.6x coverage).


Balance Sheet


Discover healthy companies